• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

报告比值比及其相对于比例报告比值比的优势。

The reporting odds ratio and its advantages over the proportional reporting ratio.

作者信息

Rothman Kenneth J, Lanes Stephan, Sacks Susan T

机构信息

Department of Epidemiology, Boston University Medical Center, 715 Albany Street, MA 02118, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23. doi: 10.1002/pds.1001.

DOI:10.1002/pds.1001
PMID:15317031
Abstract

PURPOSE

The proportional reporting ratio (PRR) is the proportion of spontaneous reports for a given drug that are linked to a specific adverse outcome, divided by the corresponding proportion for all or several other drugs. The PRR is similar to the proportional mortality ratio (PMR), an old epidemiologic measure calculated from death registries and constructed in similar fashion to the PRR. The PMR has important deficiencies, however, which the PRR shares. Miettinen and Wang demonstrated that the PMR could be improved by reformulating it as an odds ratio and applying the principles of a case-control study to the measure. In this paper, we review the problem with the PRR and show how the corresponding odds ratio represents an improvement over the PRR.

METHODS

The method used is discussion and illustration by way of a hypothetical example.

RESULTS

The PRR does not estimate relative risk. If, however, a spontaneous report database is viewed as source data for a case-control study, the reporting odds ratio (ROR) can be used to estimate relative risk. Treating the data as source data for a case-control study allows for further reduction of bias by the judicious choice of controls.

CONCLUSIONS

Calculating the ROR in spontaneous report databases offers advantages over the PRR. It allows for estimation of the relative risk, and focuses attention on which people or reports should be included or excluded from the control series, permitting more deliberate elimination of biases. It also highlights the inherent weaknesses in spontaneous report data, which become more evident in light of the usual principles of control selection in case-control studies.

摘要

目的

比例报告比(PRR)是某种特定药物与特定不良结局相关的自发报告比例,除以所有其他药物或几种其他药物的相应比例。PRR类似于比例死亡率(PMR),后者是一种根据死亡登记数据计算得出的古老流行病学指标,其构建方式与PRR相似。然而,PMR存在重要缺陷,PRR也存在同样的问题。米耶蒂宁和王证明,通过将PMR重新表述为比值比并将病例对照研究的原理应用于该指标,可以对其进行改进。在本文中,我们回顾了PRR存在的问题,并展示了相应的比值比如何比PRR有所改进。

方法

所采用的方法是通过一个假设示例进行讨论和说明。

结果

PRR无法估计相对风险。然而,如果将自发报告数据库视为病例对照研究的源数据,则报告比值比(ROR)可用于估计相对风险。将数据视为病例对照研究的源数据,通过明智地选择对照,可以进一步减少偏差。

结论

在自发报告数据库中计算ROR比PRR具有优势。它可以估计相对风险,并将注意力集中在对照系列中应纳入或排除哪些人或报告,从而更有针对性地消除偏差。它还突出了自发报告数据中固有的弱点,根据病例对照研究中对照选择的通常原则,这些弱点会变得更加明显。

相似文献

1
The reporting odds ratio and its advantages over the proportional reporting ratio.报告比值比及其相对于比例报告比值比的优势。
Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23. doi: 10.1002/pds.1001.
2
Quantitative signal detection using spontaneous ADR reporting.使用自发药品不良反应报告进行定量信号检测。
Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427-36. doi: 10.1002/pds.1742.
3
The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.药物不良反应自发报告中不成比例性测量方法(报告比值比、比例报告率)的历史。
Pharmacoepidemiol Drug Saf. 2005 Apr;14(4):285-6. doi: 10.1002/pds.1058.
4
A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.中国广东省药品不良反应自发报告数据库中信号检测不均衡性测量方法的比较。
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):593-600. doi: 10.1002/pds.1601.
5
Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database.通过比较自发报告数据库和索赔数据库来检测哌醋甲酯的信号。
Regul Toxicol Pharmacol. 2011 Nov;61(2):154-60. doi: 10.1016/j.yrtph.2011.03.015. Epub 2011 Apr 9.
6
A computerized system for signal detection in spontaneous reporting system of Shanghai China.中国上海自发呈报系统中信号检测的计算机化系统。
Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):154-8. doi: 10.1002/pds.1695.
7
Drug related falls: a study in the French Pharmacovigilance database.药物相关跌倒:法国药物警戒数据库中的一项研究
Pharmacoepidemiol Drug Saf. 2005 Jan;14(1):11-6. doi: 10.1002/pds.1038.
8
Exposure-time-varying hazard function ratios in case-control studies of drug effects.药物效应病例对照研究中的暴露时间变化风险函数比。
Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):81-92. doi: 10.1002/pds.1164.
9
Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.RALES发表后的高钾血症报告——一项药物警戒研究。
Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):775-83. doi: 10.1002/pds.1275.
10
Comparing data mining methods on the VAERS database.在疫苗不良事件报告系统(VAERS)数据库上比较数据挖掘方法。
Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):601-9. doi: 10.1002/pds.1107.

引用本文的文献

1
Drug-associated postpartum hemorrhage: a comprehensive disproportionality analysis based on the FAERS database.药物相关的产后出血:基于FAERS数据库的全面不成比例性分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Sep 8. doi: 10.1007/s00210-025-04560-7.
2
Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study.降脂药物对认知功能有害吗?一项孟德尔随机化研究。
Medicine (Baltimore). 2025 Sep 5;104(36):e44260. doi: 10.1097/MD.0000000000044260.
3
Adverse drug events associated with sodium zirconium cyclosilicate: A real-world pharmacovigilance study based on the FAERS database.
与环硅酸锆钠相关的药物不良事件:一项基于FAERS数据库的真实世界药物警戒研究。
PLoS One. 2025 Sep 2;20(9):e0330340. doi: 10.1371/journal.pone.0330340. eCollection 2025.
4
Real-world safety profile of mitomycin: signal detection and time-to-onset analysis from FDA adverse event reporting system and VigiAccess databases.丝裂霉素的真实世界安全性概况:来自美国食品药品监督管理局不良事件报告系统和VigiAccess数据库的信号检测与发病时间分析
Int J Clin Pharm. 2025 Aug 28. doi: 10.1007/s11096-025-01994-0.
5
Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic and hepatobiliary risks.白蛋白结合型纳米紫杉醇与紫杉醇在胰腺癌中的不同安全性特征:聚焦血液学和肝胆风险
Sci Rep. 2025 Aug 27;15(1):31602. doi: 10.1038/s41598-025-16848-y.
6
Post-marketing safety monitoring of RSV vaccines: A real-world study based on the Vaccine Adverse Event Reporting System (VAERS).呼吸道合胞病毒疫苗的上市后安全性监测:一项基于疫苗不良事件报告系统(VAERS)的真实世界研究。
Hum Vaccin Immunother. 2025 Dec;21(1):2550857. doi: 10.1080/21645515.2025.2550857. Epub 2025 Aug 27.
7
Sex-specific risk signals and onset patterns of drug-induced peripheral neuralgia: a 20-year pharmacovigilance analysis based on FAERS real-world dat.药物性周围神经痛的性别特异性风险信号及发病模式:基于FAERS真实世界数据的20年药物警戒分析
Front Pharmacol. 2025 Aug 8;16:1628362. doi: 10.3389/fphar.2025.1628362. eCollection 2025.
8
Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess.非奈利酮不良反应的特征分析:来自世界卫生组织药物不良反应数据库(WHO-VigiAccess)的深入分析
Front Pharmacol. 2025 Aug 7;16:1545148. doi: 10.3389/fphar.2025.1545148. eCollection 2025.
9
Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database.抗精神病药物相关不良事件的年龄和性别差异:对美国食品药品监督管理局不良事件数据库的分析
Int J Geriatr Psychiatry. 2025 Aug;40(8):e70142. doi: 10.1002/gps.70142.
10
Assessment of drug-related migraine in a real-world large-scale database.在一个真实世界的大规模数据库中对药物相关性偏头痛进行评估。
Front Pharmacol. 2025 Jul 25;16:1647088. doi: 10.3389/fphar.2025.1647088. eCollection 2025.